ZIM Laboratories Limited (BOM:541400)
70.84
-5.26 (-6.91%)
At close: Jan 21, 2026
ZIM Laboratories Revenue
ZIM Laboratories had revenue of 887.11M INR in the quarter ending September 30, 2025, a decrease of -3.72%. This brings the company's revenue in the last twelve months to 3.66B, down -5.82% year-over-year. In the fiscal year ending March 31, 2025, ZIM Laboratories had annual revenue of 3.79B with 3.16% growth.
Revenue (ttm)
3.66B
Revenue Growth
-5.82%
P/S Ratio
0.95
Revenue / Employee
6.34M
Employees
577
Market Cap
3.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.79B | 116.16M | 3.16% |
| Mar 31, 2024 | 3.68B | -310.92M | -7.80% |
| Mar 31, 2023 | 3.99B | 651.00M | 19.52% |
| Mar 31, 2022 | 3.34B | 261.64M | 8.51% |
| Mar 31, 2021 | 3.07B | 295.19M | 10.63% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sudarshan Pharma Industries | 5.92B |
| Albert David | 3.16B |
| Amanta Healthcare | 2.76B |
| Kilitch Drugs (India) | 2.09B |
| Everest Organics | 1.89B |
| Medico Remedies | 1.72B |
| Medicamen Biotech | 1.70B |
| Jenburkt Pharmaceuticals | 1.59B |
ZIM Laboratories News
- 7 weeks ago - Why ZIM Laboratories has received CDSCO approval for its new Naproxen + Esomeprazole capsules - Business Upturn
- 6 months ago - ZIM Laboratories secures marketing authorization in Australia for urology drug combination - Business Upturn
- 6 months ago - ZIM Laboratories shares in focus as company gets first marketing approval in Australia - Business Upturn